The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
The p53/miR-34 axis in development and disease
Open accessAbstract
The tumor suppressor p53 is one of the most frequently mutated genes in human cancers. MicroRNAs (miRNAs) are small non-protein coding RNAs that regulate gene expression on the post-transcriptional level. Recently, it was shown that p53 regulates the expression of several miRNAs, thereby representing an important mechanism of p53 signaling. Several independent studies identified the members of the miR-34 family as the most prevalent p53-induced miRNAs. miR-34s are frequently silenced in variety of tumor entities, suggesting that they are important tumor suppressors. Indeed, ectopic expression of miR-34s inhibits proliferation, epithelial to mesenchymal transition, migration, invasion, and metastasis of various cancer cell entities. Moreover, delivery or re-expression of miR-34 leads to notable repression of tumor growth and metastasis in cancer mouse models, and may therefore represent an efficient strategy for future cancer therapeutics. Besides their crucial functions in cancer, members of the miR-34 family also play important roles in spermatogenesis, stem cell differentiation, neuronal development, aging, and cardiovascular functions. Consequently, miR-34 has also been implicated in various non-cancerous diseases, such as brain disorders, osteoporosis, and cardiovascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hu, K., Xie, Y.-Y., Zhang, C., Ouyang, D.-S., Long, H.-Y., Sun, D.-N., Long, L.-L., Feng, L., Li, Y., & Xiao, B. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-115 · Cited by 182
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 3×
“The p53 tumor suppressor protein is a transcription factor that regulates the expression of stress response genes and mediates a variety of anti-proliferative processes (Vogelstein et al., 2000). p53 represents one of the most important proteins that protect against cancer.”
BackgroundInfluentialThe widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.
Miyashita, T., Krajewski, S., Krajewska, M., Wang, H., Lin, H., Liebermann, D. A., Hoffman‐Liebermann, B., & Reed, J. C. (1994) · PubMed · Cited by 2,143
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · cited 3×
“Subsequent studies confirmed the pro-apoptotic functions of miR-34a in various cancer entities and several anti-apoptotic genes were identified as miR-34 targets (Chang et al., 2007; Raver-Shapira et al., 2007; Cao et al., 2013).”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 1×
“Interestingly, pharmacological or siRNAmediated inhibition of LDHA resulted in suppression of cancer cell proliferation (Fantin et al., 2006).”
BackgroundPetitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“TP53 mutations can be somatic or germline, where patients that inherit a mutant TP53 allele (Li–Fraumeni syndrome) develop a variety of early onset malignancies with 100% penetrance (Petitjean et al., 2007).”
BackgroundMicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship
Pasquinelli, A. E. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3162 · Cited by 1,593
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
Self-citationTranscriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citationWhen mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Modulation of microRNA processing by p53
Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., & Miyazono, K. (2009) · Nature · doi:10.1038/nature08199 · Cited by 1,124
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
A microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Rivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011) · Genes & Cancer · doi:10.1177/1947601911408889 · Cited by 1,033
Tarasov, V., Jung, P., Verdoodt, B., Lodygin, D., Epanchintsev, A., Menssen, A., Meister, G., & Hermeking, H. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4436 · Cited by 923
Self-citationTumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
Self-citationTazawa, H., Tsuchiya, N., Izumiya, M., & Nakagama, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707351104 · Cited by 903
MicroRNA-34a regulates cardiac ageing and function.
Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., et al. (2013) · Nature · doi:10.1038/nature11919 · Cited by 821
Self-citationMicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
Welch, C., Chen, Y., & Stallings, R. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210293 · Cited by 805
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
Self-citationIL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753 · cited 3×
“(E) Representation of the IL-6R/STAT3/miR- 34a feedback loop identified and characterized by Rokavec et al. (2014) .”
BackgroundSelf-citationmiR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
The Long and Short of MicroRNA
Yates, L. A., Norbury, C. J., & Gilbert, R. J. C. (2013) · Cell · doi:10.1016/j.cell.2013.04.003 · Cited by 704
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., & Bader, A. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0655 · Cited by 677
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression
Cheung, O., Puri, P., Eicken, C., Contos, M. J., Mirshahi, F., Maher, J. W., Kellum, J. M., Min, H., Luketic, V. A., & Sanyal, A. J. (2008) · Hepatology · doi:10.1002/hep.22569 · Cited by 658
Corney, D. C., Flesken-Nikitin, A., Godwin, A. K., Wang, W., & Nikitin, A. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1585 · Cited by 644
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Li, Y., Guessous, F., Zhang, Y., DiPierro, C., Kefas, B., Johnson, E., Marcinkiewicz, L., Jiang, J., Yang, Y., Schmittgen, T. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0529 · Cited by 614
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Self-citationToyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600
Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
Cermelli, S., Ruggieri, A., Marrero, J. A., Ioannou, G. N., & Beretta, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023937 · Cited by 564
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Kong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., et al. (2011) · Acta Diabetologica · doi:10.1007/s00592-010-0226-0 · Cited by 529
MicroRNAs in the p53 network: micromanagement of tumour suppression
Hermeking, H. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3318 · Cited by 518 · cited 5×
“Since then, many of these miRNAs have been implicated as important mediators of p53 functions (Hermeking, 2012). p53 not only regulates miRNAs at the transcriptional level, but also regulates the processing/maturation of certain miRNAs.”
BackgroundInfluentialSelf-citationDownregulation of CCND1 and CDK6 by miR‐34a induces cell cycle arrest
Sun, F., Fu, H., Liu, Q., Tie, Y., Zhu, J., Xing, R., Sun, Z., & Zheng, X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.057 · Cited by 514
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110235 · Cited by 514
Hermeking, H. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.028 · Cited by 494
Self-citationMiñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola, S., Kagerbauer, B., Espinosa-Parrilla, Y., Ferrer, I., Estivill, X., & Martí, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 482
Sperm-borne microRNA-34c is required for the first cleavage division in mouse
Liu, W.-M., Pang, R. T. K., Chiu, P. C. N., Wong, B. P. C., Lao, K., Lee, K.-F., & Yeung, W. S. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110368109 · Cited by 461
p53 Research: The Past Thirty Years and the Next Thirty Years
Lane, D., & Levine, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000893 · Cited by 454
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial–mesenchymal transition
Kim, N. H., Kim, H. S., Li, X.-Y., Lee, I., Choi, H.-S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201103097 · Cited by 432
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Roth, C., Rack, B., Müller, V., Janni, W., Pantel, K., & Schwarzenbach, H. (2010) · Breast Cancer Research · doi:10.1186/bcr2766 · Cited by 430
Bernardo, B. C., Gao, X.-M., Winbanks, C. E., Boey, E. J. H., Tham, Y. K., Kiriazis, H., Gregorevic, P., Obad, S., Kauppinen, S., Du, X.-J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206432109 · Cited by 429
Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., & Zheng, X. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.09.035 · Cited by 418
The role of mutant p53 in human cancer
Goh, A. M., Coffill, C. R., & Lane, D. P. (2011) · The Journal of Pathology · doi:10.1002/path.2784 · Cited by 398
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Ji, Q., Hao, X., Meng, Y., Zhang, M., DeSano, J., Fan, D., & Xu, L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-266 · Cited by 394
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Choi, Y. J., Lin, C.-P., Ho, J. J., He, X., Okada, N., Bu, P., Zhong, Y., Kim, S. Y., Bennett, M. J., Chen, C., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2366 · Cited by 382
Matsumoto, S., Sakata, Y., Suna, S., Nakatani, D., Usami, M., Hara, M., Kitamura, T., Hamasaki, T., Nanto, S., Kawahara, Y., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301209 · Cited by 374
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Bu, P., Chen, K.-Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., Goerger, J. P., Sun, J., Witherspoon, M., Rakhilin, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.002 · Cited by 357
The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila
Liu, N., Landreh, M., Cao, K., Abe, M., Hendriks, G.-J., Kennerdell, J. R., Zhu, Y., Wang, L.-S., & Bonini, N. M. (2012) · Nature · doi:10.1038/nature10810 · Cited by 356
microRNA-34c is a novel target to treat dementias
Zovoilis, A., Agbemenyah, H. Y., Agis‐Balboa, R. C., Stilling, R. M., Edbauer, D., Rao, P., Farinelli, L., Delalle, I., Schmitt, A., Falkai, P., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.327 · Cited by 353
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC
Christoffersen, N. R., Shalgi, R., Frankel, L. B., Leucci, E., Lees, M., Klausen, M., Pilpel, Y., Nielsen, F. C., Oren, M., & Lund, A. H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.109 · Cited by 352 · cited 4×
“cell cycle progression and proliferation, are directly repressed by miR-34s (Wei et al., 2008; Christoffersen et al., 2010; Pulikkan et al., 2010).”
BackgroundInfluentialCastro, R. E., Ferreira, D. M. S., Afonso, M. B., Borralho, P. M., Machado, M. V., Cortez-Pinto, H., & Rodrigues, C. M. P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.008 · Cited by 350
Alterations in MicroRNA Expression Contribute to Fatty Acid–Induced Pancreatic β-Cell Dysfunction
Lovis, P., Roggli, E., Laybutt, D. R., Gattesco, S., Yang, J.-Y., Widmann, C., Abderrahmani, A., & Regazzi, R. (2008) · Diabetes · doi:10.2337/db07-1252 · Cited by 345
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Gallardo, E., Navarro, A., Viñolas, N., Marrades, R. M., Diaz, T., Gel, B., Quera, A., Bandres, E., Garcia-Foncillas, J., Ramirez, J., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp219 · Cited by 342
MicroRNA-34a regulation of endothelial senescence
Ito, T., Yagi, S., & Yamakuchi, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.012 · Cited by 336
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Fujita, Y., Kojima, K., Hamada, N., Ohhashi, R., Akao, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.086 · Cited by 331
Zhao, T., Li, J., & Chen, A. F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00192.2010 · Cited by 329
Yamada, H., Suzuki, K., Ichino, N., Ando, Y., Sawada, A., Osakabe, K., Sugimoto, K., Ohashi, K., Teradaira, R., Inoue, T., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.021 · Cited by 327
A Functional Screen Identifies miR-34a as a Candidate Neuroblastoma Tumor Suppressor Gene
Cole, K. A., Attiyeh, E. F., Mosse, Y. P., Laquaglia, M. J., Diskin, S. J., Brodeur, G. M., & Maris, J. M. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2102 · Cited by 316
Vogt, M., Munding, J., Grüner, M., Liffers, S.-T., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., & Hermeking, H. (2011) · Virchows Archiv · doi:10.1007/s00428-010-1030-5 · Cited by 309
Self-citationp53 and MicroRNA-34 Are Suppressors of Canonical Wnt Signaling
Kim, N. H., Kim, H. S., Kim, N.-G., Lee, I., Choi, H.-S., Li, X.-Y., Kang, S. E., Cha, S. Y., Ryu, J. K., Na, J. M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001744 · Cited by 308
Dong, P., Karaayvaz, M., Jia, N., Kaneuchi, M., Hamada, J., Watari, H., Sudo, S., Ju, J., & Sakuragi, N. (2013) · Oncogene · doi:10.1038/onc.2012.334 · Cited by 307
Pramanik, D., Campbell, N. R., Karikari, C., Chivukula, R., Kent, O. A., Mendell, J. T., & Maitra, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0152 · Cited by 296
The MYCN oncogene is a direct target of miR-34a
Wei, J. S., Song, Y. K., Durinck, S., Chen, Q.-R., Cheuk, A. T. C., Tsang, P., Zhang, Q., Thiele, C. J., Slack, A., Shohet, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.154 · Cited by 296
Toiyama, Y., Hur, K., Tanaka, K., Inoue, Y., Kusunoki, M., Boland, C. R., & Goel, A. (2014) · Annals of Surgery · doi:10.1097/sla.0b013e3182a6909d · Cited by 294
Hashimi, S. T., Fulcher, J. A., Chang, M. H., Gov, L., Wang, S., & Lee, B. (2009) · Blood · doi:10.1182/blood-2008-09-179150 · Cited by 291
Role of miR-34c microRNA in the late steps of spermatogenesis
Bouhallier, F., Allioli, N., Lavial, F., Chalmel, F., Perrard, M.-H., Durand, P., Samarut, J., Pain, B., & Rouault, J.-P. (2010) · RNA · doi:10.1261/rna.1963810 · Cited by 289
Abu-Halima, M., Hammadeh, M., Schmitt, J., Leidinger, P., Keller, A., Meese, E., & Backes, C. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.11.054 · Cited by 285
Menssen, A., Hydbring, P., Kapelle, K., Vervoorts, J., Diebold, J., Lüscher, B., Larsson, L.-G., & Hermeking, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105304109 · Cited by 275
Self-citationWang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., Huang, L., Liu, Y., Zhang, L., & Qin, C. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.006 · Cited by 271
Altered Profile of Seminal Plasma MicroRNAs in the Molecular Diagnosis of Male Infertility
Wang, C., Yang, C., Chen, X., Yao, B., Yang, C., Zhu, C., Li, L., Wang, J., Li, X., Shao, Y., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.169714 · Cited by 271
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Östling, P., Leivonen, S.-K., Aakula, A., Kohonen, P., Mäkelä, R., Hagman, Z., Edsjö, A., Kangaspeska, S., Edgren, H., Nicorici, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2421 · Cited by 270
Lee, J., Padhye, A., Sharma, A., Song, G., Miao, J., Mo, Y.-Y., Wang, L., & Kemper, J. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094524 · Cited by 263
microRNA as Repressors of Stress-Induced Anxiety: The Case of Amygdalar miR-34
Haramati, S., Navon, I., Issler, O., Ezra-Nevo, G., Gil, S., Zwang, R., Hornstein, E., & Chen, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1673-11.2011 · Cited by 252
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
Mudduluru, G., Ceppi, P., Kumarswamy, R., Scagliotti, G. V., Papotti, M., & Allgayer, H. (2011) · Oncogene · doi:10.1038/onc.2011.13 · Cited by 252
Choi, S., Fu, T., Seok, S., Kim, D., Yu, E., Lee, K., Kang, Y., Li, X., Kemper, B., & Kemper, J. K. (2013) · Aging Cell · doi:10.1111/acel.12135 · Cited by 249
miRNA-34c regulates Notch signaling during bone development
Bae, Y., Yang, T., Zeng, H.-C., Campeau, P. M., Chen, Y., Bertin, T., Dawson, B. C., Munivez, E., Tao, J., & Lee, B. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds129 · Cited by 237
Rao, D. S., O'Connell, R. M., Chaudhuri, A. A., Garcia-Flores, Y., Geiger, T. L., & Baltimore, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.013 · Cited by 234
Bao, J., Li, D., Wang, L., Wu, J., Hu, Y., Wang, Z., Chen, Y., Cao, X., Jiang, C., Yan, W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328054 · Cited by 230
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., Chen, H., Ding, F., Wang, X., & Liu, Z. (2013) · Oncogene · doi:10.1038/onc.2012.432 · Cited by 228
p53 Regulates Cell Cycle and MicroRNAs to Promote Differentiation of Human Embryonic Stem Cells
Jain, A. K., Allton, K., Iacovino, M., Mahen, E., Milczarek, R. J., Zwaka, T. P., Kyba, M., & Barton, M. C. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001268 · Cited by 227
miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2
Wei, J., Shi, Y., Zheng, L., Zhou, B., Inose, H., Wang, J., Guo, X. E., Grosschedl, R., & Karsenty, G. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201201057 · Cited by 218
miR-335 and miR-34a Promote Renal Senescence by Suppressing Mitochondrial Antioxidative Enzymes
Bai, X.-Y., Ma, Y., Ding, R., Fu, B., Shi, S., & Chen, X.-M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040367 · Cited by 212
Kojima, K., Fujita, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2010) · The Prostate · doi:10.1002/pros.21185 · Cited by 205
Kaller, M., Liffers, S.-T., Oeljeklaus, S., Kuhlmann, K., Röh, S., Hoffmann, R., Warscheid, B., & Hermeking, H. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010462 · Cited by 201
Self-citationIntact p53-Dependent Responses in miR-34–Deficient Mice
Concepcion, C. P., Han, Y.-C., Mu, P., Bonetti, C., Yao, E., D'Andrea, A., Vidigal, J. A., Maughan, W. P., Ogrodowski, P., & Ventura, A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002797 · Cited by 197
Suzuki, H., Yamamoto, E., Nojima, M., Kai, M., Yamano, H.-O., Yoshikawa, K., Kimura, T., Kudo, T., Harada, E., Sugai, T., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq203 · Cited by 196
Yan, K., Gao, J., Yang, T., Ma, Q., Qiu, X., Fan, Q., & Ma, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033778 · Cited by 195
Eichelser, C., Flesch-Janys, D., Chang-Claude, J., Pantel, K., & Schwarzenbach, H. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.205161 · Cited by 195
Kang, J., Kim, E., Kim, W., Seong, K. M., Youn, H., Kim, J. W., Kim, J., & Youn, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490482 · Cited by 188
P53 is a tumor suppressor gene
Levine, A. J., Finlay, C. A., & Hinds, P. W. (2004) · Cell · doi:10.1016/s0092-8674(04)00036-4 · Cited by 185
microRNA-34a regulates neurite outgrowth, spinal morphology, and function
Agostini, M., Tucci, P., Steinert, J. R., Shalom-Feuerstein, R., Rouleau, M., Aberdam, D., Forsythe, I. D., Young, K. W., Ventura, A., Concepcion, C. P., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112063108 · Cited by 185
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status
Li, S., Chen, X., Zhang, H., Liang, X., Xiang, Y., Yu, C., Zen, K., Li, Y., & Zhang, C.-Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800509-jlr200 · Cited by 184
miR-34a Regulates Mouse Neural Stem Cell Differentiation
Aranha, M. M., Santos, D. M., Solá, S., Steer, C. J., & Rodrigues, C. M. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021396 · Cited by 184
Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging
Li, X., Khanna, A., Li, N., & Wang, E. (2011) · Aging · doi:10.18632/aging.100371 · Cited by 183
Tabuchi, T., Satoh, M., Itoh, T., & Nakamura, M. (2012) · Clinical Science · doi:10.1042/cs20110563 · Cited by 174
de Antonellis, P., Medaglia, C., Cusanelli, E., Andolfo, I., Liguori, L., De Vita, G., Carotenuto, M., Bello, A., Formiggini, F., Galeone, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024584 · Cited by 171
Du, R., Sun, W., Xia, L., Zhao, A., Yu, Y., Zhao, L., Wang, H., Huang, C., & Sun, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030771 · Cited by 169
MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9
Yang, J., Chen, D., He, Y., Meléndez, A., Feng, Z., Hong, Q., Bai, X., Li, Q., Cai, G., Wang, J., et al. (2011) · AGE · doi:10.1007/s11357-011-9324-3 · Cited by 166
Craig, V. J., Cogliatti, S. B., Imig, J., Renner, C., Neuenschwander, S., Rehrauer, H., Schlapbach, R., Dirnhofer, S., Tzankov, A., & Müller, A. (2011) · Blood · doi:10.1182/blood-2010-10-312231 · Cited by 166
SNAIL and miR‐34a feed‐forward regulation of ZNF281/ZBP99 promotes epithelial–mesenchymal transition
Hahn, S., Jackstadt, R., Siemens, H., Hünten, S., & Hermeking, H. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.236 · Cited by 165
Self-citationMarshall, G. M., Liu, P. Y., Gherardi, S., Scarlett, C. J., Bedalov, A., Xu, N., Iraci, N., Valli, E., Ling, D., Thomas, W. D., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002135 · Cited by 164
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
Ahn, Y., Gibbons, D. L., Chakravarti, D., Creighton, C. J., Rizvi, Z. H., Adams, H. P., Pertsemlidis, A., Gregory, P. A., Wright, J. A., Goodall, G. J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63608 · Cited by 162
Niederer, F., Trenkmann, M., Ospelt, C., Karouzakis, E., Neidhart, M., Stańczyk, J., Kolling, C., Gay, R. E., Detmar, M. J., Gay, S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34334 · Cited by 161
Fu, T., Choi, S., Kim, D.-H., Seok, S., Suino-Powell, K. M., Xu, H. E., & Kemper, J. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205951109 · Cited by 160
miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53
Navarro, F., Gutman, D. A., Meire, E., Cáceres, M., Rigoutsos, I., Bentwich, Z., & Lieberman, J. (2009) · Blood · doi:10.1182/blood-2009-02-205062 · Cited by 155
Yu, F., Jiao, Y., Zhu, Y., Wang, Y., Zhu, J., Cui, X., Liu, Y., He, Y., Park, E.-Y., Zhang, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280768 · Cited by 152
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
Wu, J., Wu, G., Lv, L., Ren, Y.-F., Zhang, X., Xue, Y.-F., Li, G., Lu, X., Sun, Z. S., & Tang, K. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr304 · Cited by 152
Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF
Roy, S., Levi, E., Majumdar, A. P. N., & Sarkar, F. H. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-58 · Cited by 151
Kress, T. R., Cannell, I. G., Brenkman, A. B., Samans, B., Gaestel, M., Roepman, P., Burgering, B. M. T., Bushell, M., Rosenwald, A., & Eilers, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.023 · Cited by 149
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.
Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., & Björkqvist, M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr111 · Cited by 145
Pulikkan, J. A., Peramangalam, P. S., Dengler, V., Ho, P. A., Preudhomme, C., Meshinchi, S., Christopeit, M., Nibourel, O., Müller‐Tidow, C., Bohlander, S. K., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281600 · Cited by 144
Siemens, H., Neumann, J. H. L., Jackstadt, R., Mansmann, U., Horst, D. A., Kirchner, T., & Hermeking, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1703 · Cited by 144
Self-citationXia, J., Duan, Q., Ahmad, A., Bao, B., Banerjee, S., Shi, Y., Ma, J., Geng, J., Chen, Z., Rahman, K. W., et al. (2012) · Current Drug Targets · doi:10.2174/138945012804545597 · Cited by 144
A miR‐34a‐SIRT6 axis in the squamous cell differentiation network
Lefort, K., Brooks, Y., Ostano, P., Cario, M., Calpini, V., Guinea‐Viniegra, J., Albinger‐Hegyi, A., Hoetzenecker, W., Kolfschoten, I., Wagner, E. F., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.156 · Cited by 143
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression
Hwang, C., Matoso, A., Corney, D. C., Flesken‐Nikitin, A., Körner, S., Wang, W., Boccaccio, C., Thorgeirsson, S. S., Comoglio, P. M., Hermeking, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017536108 · Cited by 140
Self-citationSiemens, H., Jackstadt, R., Kaller, M., & Hermeking, H. (2013) · Oncotarget · doi:10.18632/oncotarget.1202 · Cited by 140
Self-citationSilber, J., Skanderup, A. J., Ozawa, T., Harinath, G., Pedraza, A. M., Sander, C., Holland, E. C., & Huse, J. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033844 · Cited by 139
Alternative polyadenylation and miR‐34 family members regulate tau expression
Dickson, J. R., Kruse, C., Montagna, D. R., Finsen, B. R., & Wolfe, M. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12437 · Cited by 137
Wang, W., Cheng, B., Miao, L., Mei, Y., & Wu, M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.97 · Cited by 137
Stilbene derivatives promote Ago2-dependent tumour-suppressive microRNA activity
Hagiwara, K., Kosaka, N., Yoshioka, Y., Takahashi, R., Takeshita, F., & Ochiya, T. (2012) · Scientific Reports · doi:10.1038/srep00314 · Cited by 137
miR-34b Targets Cyclic AMP–Responsive Element Binding Protein in Acute Myeloid Leukemia
Pigazzi, M., Manara, E., Baron, E., & Basso, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3404 · Cited by 135
Kumazaki, M., Noguchi, S., Yasui, Y., Iwasaki, J., Shinohara, H., Yamada, N. O., & Akao, Y. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.04.006 · Cited by 132
Garofalo, M., Jeon, Y.-J., Nuovo, G. J., Middleton, J. D., Secchiero, P., Joshi, P., Alder, H., Nazaryan, N., Leva, G. D., Romano, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067581 · Cited by 131
MicroRNA-34c Enhances Murine Male Germ Cell Apoptosis through Targeting ATF1
Liang, X., Zhou, D., Wei, C., Luo, H., Liu, J., Fu, R., & Cui, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033861 · Cited by 128
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
Tivnan, A., Tracey, L., Buckley, P. G., Alcock, L., Davidoff, A. M., & Stallings, R. L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-33 · Cited by 126
Majid, S., Dar, A. A., Saini, S., Shahryari, V., Arora, S., Zaman, M. S., Chang, I., Yamamura, S., Tanaka, Y., Chiyomaru, T., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2952 · Cited by 126
DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer
Wang, Z., Chen, Z., Gao, Y., Li, N., Li, B., Tan, F., Tan, X., Lü, N., Sun, Y., Sun, J., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.5.14550 · Cited by 125
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 124
Feng, Y., Huang, W., Meng, W., Jegga, A. G., Wang, Y., Cai, W., Kim, H. W., Pasha, Z., Wen, Z., Rao, F., et al. (2014) · Stem Cells · doi:10.1002/stem.1571 · Cited by 121
Dang, Y., Luo, D., Rong, M., & Chen, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061054 · Cited by 121
Li, W., Chen, C., Xu, M., Guo, J., Li, Y., Xia, Q., Liu, H., He, J., Yu, H., & Zhu, L. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08075.x · Cited by 117
Mackiewicz, M., Huppi, K. E., Pitt, J. J., Dorsey, T. H., Ambs, S., & Caplen, N. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1690-0 · Cited by 115
Kim, N. H., Cha, Y. H., Kang, S. E., Lee, Y. M., Lee, I., Cha, S. Y., Ryu, J. K., Na, J. M., Park, C., Yoon, H., et al. (2013) · Cell Cycle · doi:10.4161/cc.24739 · Cited by 111
ANALYSIS OF SERUM MICRO-RNAs AS POTENTIAL BIOMARKER IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Akbaş, F., Coşkunpınar, E. M., Aynacı, E., Oltulu, Y. M., & Yildiz, P. (2012) · Experimental Lung Research · doi:10.3109/01902148.2012.689088 · Cited by 111
Vinall, R., Ripoll, A., Wang, S., Pan, C., & White, R. D. D. (2011) · International Journal of Cancer · doi:10.1002/ijc.26256 · Cited by 110
MicroRNA-34a upregulation during seizure-induced neuronal death
Sano, T., Reynolds, J. R., Jimenez-Mateos, E. M., Matsushima, S., Taki, W., & Henshall, D. C. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.23 · Cited by 107
Craig, V. J., Tzankov, A., Flori, M., Schmid, C. A., Bader, A. G., & Mueller, A. (2012) · Leukemia · doi:10.1038/leu.2012.110 · Cited by 107
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer
Kalimutho, M., Cecilia, S. D., Blanco, G. D. V., Roviello, F., Sileri, P., Cretella, M., Formosa, A., Corso, G., Marrelli, D., Pallone, F., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.82 · Cited by 101
MicroRNA-34a Modulates MDM4 Expression via a Target Site in the Open Reading Frame
Mandke, P., Wyatt, N., Fraser, J., Bates, B., Berberich, S. J., & Markey, M. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042034 · Cited by 100
Ji, X., Wang, Z., Geamanu, A., Goja, A., Sarkar, F. H., & Gupta, S. V. (2012) · International Journal of Cancer · doi:10.1002/ijc.27549 · Cited by 98
Shen, Z., Zhan, G., Ye, D., Ren, Y., Cheng, L., Wu, Z., & Guo, J. (2012) · Medical Oncology · doi:10.1007/s12032-011-0156-x · Cited by 98
Circulating miR‐34a levels are reduced in colorectal cancer
Nugent, M., Miller, N., & Kerin, M. J. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23174 · Cited by 97
miR-34 is maternally inherited in Drosophila melanogaster and Danio rerio
Soni, K., Choudhary, A., Patowary, A., Singh, A. R., Bhatia, S., Sivasubbu, S., Chandrasekaran, S., & Pillai, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt139 · Cited by 96
Ichimura, A., Ruike, Y., Terasawa, K., Shimizu, K., & Tsujimoto, G. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.063321 · Cited by 94
Xu, Q.-F., Seeger, F., Castillo, J., Iekushi, K., Boon, R., Farcas, R., Manavski, Y., Li, Y.-G., Assmus, B., Zeiher, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.033 · Cited by 93
Systematic Proteome Analysis Identifies Transcription Factor YY1 as a Direct Target of miR-34a
Chen, Q., Yu, L., Tsang, P., Wei, J. S., Song, Y., Cheuk, A., Chung, J., Hewitt, S. M., Veenstra, T. D., & Khan, J. I. (2010) · Journal of Proteome Research · doi:10.1021/pr1006697 · Cited by 89
Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells
Cao, W., Fan, R., Wang, L., Cheng, S., Li, H., Jiang, J., Geng, M., Ye-ning, J., & Wu, Y. (2012) · Tumor Biology · doi:10.1007/s13277-012-0632-8 · Cited by 85
Self-citationKong, D., Heath, E., Chen, W., Cher, M. L., Powell, I. J., Heilbrun, L. K., Li, Y., Ali, S., Sethi, S., Hassan, O., et al. (2012) · Europe PMC (PubMed Central) · Cited by 84
Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.
Kashat, M. A., Azzouz, L., Sarkar, S., Kong, D., Li, Y., & Sarkar, F. H. (2012) · Europe PMC (PubMed Central) · Cited by 83
Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
Sotillo, E., Laver, T., Mellert, H. S., Schelter, J. M., Cleary, M. A., McMahon, S. B., & Thomas‐Tikhonenko, A. (2011) · Oncogene · doi:10.1038/onc.2010.634 · Cited by 82
Effects of MicroRNAs on Fucosyltransferase 8 (FUT8) Expression in Hepatocarcinoma Cells
Bernardi, C., Soffientini, U., Piacente, F., & Tonetti, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076540 · Cited by 74
miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44
Zhao, H., Ma, B., Wang, Y., Han, T., Zheng, L., Sun, C., Liu, T., ZHANG, Y., Qiu, X., & Fan, Q. (2013) · Oncology Reports · doi:10.3892/or.2013.2234 · Cited by 72
miR-34b regulates multiciliogenesis during organ formation in zebrafish
Wang, L., Fu, C., Fan, H.-B., Du, T., Dong, M., Chen, Y., Jin, Y., Zhou, Y., Deng, M., Gu, A., et al. (2013) · Development · doi:10.1242/dev.092825 · Cited by 72
Lee, Y. L., Peng, Q., Fong, S. W., Chen, A. C. H., Lee, C., Ng, E. H. Y., Nagy, A., & Yeung, W. S. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045633 · Cited by 70
Chang, S.-J., Weng, S.-L., Hsieh, J.-Y., Wang, T.-Y., Chang, M., & Wang, H.-W. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-65 · Cited by 68
Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages
Sukata, T., Sumida, K., Kushida, M., Ogata, K., Miyata, K., Yabushita, S., & Uwagawa, S. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.10.013 · Cited by 67
Duan, W., Xu, Y., Dong, Y., Cao, L., Tong, J., & Zhou, X. (2013) · Journal of Radiation Research · doi:10.1093/jrr/rrs136 · Cited by 58
Hui, C., Fu, Y., Lijia, Y., Yi, L., Hongxia, X., Zhou, Y. G., Jundong, Z., Zhang, Q., & Mi, M. (2012) · Breast Cancer Research · doi:10.1186/bcr3194 · Cited by 53
MiR-34a Represses Numbl in Murine Neural Progenitor Cells and Antagonizes Neuronal Differentiation
Fineberg, S. K., Datta, P., Stein, C. S., & Davidson, B. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038562 · Cited by 51
Systemic mirnas as potential biomarkers for malignancy
Healy, N. A., Heneghan, H., Miller, N., Osborne, C. K., Schiff, R., & Kerin, M. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27642 · Cited by 49
MicroRNA-34a Suppresses Cell Proliferation by Targeting LMTK3 in Human Breast Cancer MCF-7 Cell Line
Zhao, G.-Q., Guo, J., Li, D., Jia, C., Yin, W., Sun, R., Lv, Z., & Cong, X. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2130 · Cited by 48
MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1
Pang, R. T. K., Leung, C. O. N., Lee, C., Lam, K. K. W., Ye, T.-M., Chiu, P. C. N., & Yeung, W. S. B. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-25 · Cited by 47
A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH
Kim, H.-R., Roe, J., Lee, J., Hwang, I., Cho, E., & Youn, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.077 · Cited by 43
Correlation between microRNA-34a levels and lens opacity severity in age-related cataracts
Chien, K., Chen, S.-J., Liu, H., Chang, H.-M., Woung, L., Liang, C.-M., Chen, J., Lin, T.-J., Chiou, S.-H., & Peng, C.-H. (2013) · Eye · doi:10.1038/eye.2013.90 · Cited by 41
Wirsing, A., Senkel, S., Klein‐Hitpaß, L., & Ryffel, G. U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027438 · Cited by 39
Wan, M., Gao, B., Sun, F., Tang, Y., Ye, L., Fan, Y., Klein, O. D., Zhou, X., & Zheng, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050090 · Cited by 38
Wang, Y., Guo, F., Pan, C.-F., Lou, Y., Zhang, P., Guo, S., Yin, J., & Deng, Z. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012123 · Cited by 36
MiR-34a inhibits lymphatic metastasis potential of mouse hepatoma cells
Guo, Y., Li, S., Qu, J., Wang, S., Dang, Y., Fan, J., Yu, S., & Zhang, J. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0827-0 · Cited by 35
The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation
Wang, Z., & Burke, P. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.12.009 · Cited by 31
c-MYC and SIRT1 locked in a vicious cycle
Menssen, A., & Hermeking, H. (2012) · Oncotarget · doi:10.18632/oncotarget.440 · Cited by 19
Self-citation
Cited by
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Zhang, L., Liao, Y., & Tang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1059-5 · Cited by 510
Role of microRNAs in translation regulation and cancer
Oliveto, S., Mancino, M., Manfrini, N., & Biffo, S. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.45 · Cited by 431
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies
Kim, T., & Croce, C. M. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01050-9 · Cited by 407
Inflammatory breast cancer biology: the tumour microenvironment is key
Lim, B., Woodward, W. A., Wang, X., Reuben, J. M., & Ueno, N. T. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0010-y · Cited by 326
Alternative mechanisms of miR-34a regulation in cancer
Slabáková, E., Culig, Z., Remšík, J., & Souček, K. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.495 · Cited by 264
Metadata
- Authors
- Rokavec, M., Li, H., Jiang, L., & Hermeking, H.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-09
- Volume
- 6
- Issue
- 3
- Pages
- 214-230
- ISSN
- 1674-2788 (ISSN-L)
- OpenAlex
- W2168513601
- Cited by
- 354
- References
- 187
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.